Immunoblotting further confirmed that USP15 was upregulated in a panel of NSCLC cell lines, including BEAS‐2B bronchial epithelial cells and MRC‐5 fetal lung fibroblasts, compared with nontumorigenic controls (Figure 1C). Here, USP15 is linked to non-small cell lung carcinoma.